Real Questions, Expert-Informed Answers
9,267 answers to real cancer questions, grounded in published medical literature and NCCN guidelines.
Browse all 9,267 answers — page 1 of 186
COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian...
Καταλαβαίνω ότι έχετε σημαντικές ανησυχίες σχετικά με το εμβόλιο και τον καρκίνο του μαστού σας. Θα σας δώσω μια σαφή, επιστημονική απάντηση βασισμένη στο άρθρο που μοιράστηκες και
EXCLI J . 2025 Jul 1:24:690-707. doi: 10.17179/excli2025-8400. eCollection 2025. COVID-19 vaccination, all-cause...
Ευχαριστώ που μοιράστηκες το συγκεκριμένο άρθρο. Τώρα μπορώ να σας δώσω μια ακριβή, επιστημονική ανάλυση του τι λέει πραγματικά και τι σημαίνει για εσάς. --- Τι Λέει το Άρθρο Ma
Https://pubmed.ncbi.nlm.nih.gov/40881928/, https://pmc.ncbi.nlm.nih.gov/articles/PMC12381369/,...
Καταλαβαίνω ότι ψάχνετε για εναλλακτικά συμπληρώματα που να υποστηρίζουν τα λευκά αιμοσφαίρια κατά τη θεραπεία με Kisqali ribociclib. Αυτή είναι μια πολύ πρακτική ερώτηση. --- Σ
Breast cancer and mRNA COVID-19 vaccinations
I appreciate you sharing this context, but I notice the patient information and specific question appear to be incomplete or cut off in your message. I can see: - Patient context:
What is the best treatment for metastatic myxoid liposarcoma
I appreciate your question about metastatic myxoid liposarcoma treatment. However, I notice your question came through without the specific patient context that would help me give
What is a metabolic protocol for myxoid liposarcoma
I appreciate your question about metabolic protocols for myxoid liposarcoma. However, I notice your message came through without the specific patient question details, so I want to
What lifestyle changes are recommended for null patients
I appreciate your question, but I need to clarify what you're asking about. The term "null patients" isn't standard medical terminology in oncology or general healthcare that I'm f
Will cryoablation help with myxoid liposarcoma in vertabrae
I appreciate this specific question about a rare and challenging tumor type. Let me provide educational context about cryoablation and myxoid liposarcoma to help you understand wha
Understanding Your Day 10 Post-Infusion Experience with Gazyba
I'd be happy to help you understand what's happening at this stage of your treatment. However, I notice you haven't shared specific details about your symptoms or concerns on Day 1
What is the latest in breakthrough treatment for metastatic prostate CA
Metastatic prostate cancer treatment has evolved significantly in recent years. Here's what's currently considered cutting-edge: 1. Precision Medicine Based on Genetic Testing O
Https://www.mskcc.org/cancer-care/integrative-medicine/herbs/arginine
Εξαιρετική έρευνα που συγκεντρώνετε. Ας δημιουργήσουμε ένα πρακτικό σχέδιο βασισμένο σε τεκμηριωμένες στρατηγικές — τυποποιημένη φροντίδα + emerging options. --- ΜΕΡΟΣ 1: ΤΥΠΟΠΟ
Https://pmc.ncbi.nlm.nih.gov/articles/PMC4888479/
Εξαιρετική ερώτηση — ειδικά αφού έχετε ολοκληρώσει 2 κύκλους Kisqali. Η νευτροπενία χαμηλά λευκά αιμοσφαίρια είναι συχνή και αντιμετωπίσιμη. Ας αναλύσουμε τι λέει η έρευνα που βρήκ
Https://pmc.ncbi.nlm.nih.gov/articles/PMC10930819/ εξληγησε
Excellent — you've found a peer-reviewed study. Let me break down what this research shows and how it applies to YOUR situation with Kisqali + glutamine. --- PART 1: WHAT THE ST
Explain more about G-CSF and how it works
I'll walk you through how G-CSF works, then explore emerging approaches beyond standard guidelines. --- PART 1: STANDARD-OF-CARE G-CSF Established How G-CSF Works: The Basic B
Though they classify it as intermediate because it has cartilage, fibroblastic and osteoblastic components
Thank you for this critical clarification. The intermediate-grade classification rather than pure low-grade significantly impacts treatment strategy and prognosis. This is an impor
Why is p16 negative a good thing in my case
Great question — this is an important prognostic marker that directly impacts your tumor's behavior and treatment approach. --- PART 1: WHAT p16 DOES The Biology p16 is a tumor
The center of the lesion is composed of cortical-type bone, sclerotic and predominantly reticular, with a large...
Based on your pathology findings and your concern about "intermediate structure with signs of low-grade osteosarcoma," I'm providing both standard-of-care approaches and emerging/i
A seemingly intermediate structurally with signs of low grade osteosarcoma low mitosis and low proliferation that...
Thank you for sharing this finding. Let me help you understand what this means in plain language. What Your Report Describes Your pathology report indicates: "Intermediate stru
Analyze my situation considering the DNA-Q and Manual Differential reports I uploaded today.
However, I don't see any documents attached to your message yet. Please upload your reports by: - Clicking the paperclip icon in the chat - Dragging and dropping PDFs or images di
What is inflammatory breast cancer
Based on your medical history and current concerns, I want to give you clear information about inflammatory breast cancer. This is especially relevant since you've been experiencin
How unusual is it for CD34+ donor cells to drop from 86% to 0% in 3 months
This is an important question, and I can help you understand what's happening with your donor cells. Let me break this down in the context of your MDS and what you've been through.
Been getting IVIG infusions every 4 weeks. Recent testing performed 5/12/26 indicates my levels are now in normal...
This is genuinely good news on the surface — your immunoglobulin levels are now normal — but given your specific situation MDS, post-allo-HSCT, CVID diagnosis, and that CD34+ chime
Where is the CVID diagnosis documented
That's an excellent and important question. Looking at your medical profile, I need to be direct with you: --- What Your Records Show Your medical profile documents: - D83.9 -
Non-hodgkins lymphoma - Has anybody had a severe, red, & itchy rash that wont go away even after rchop and radiation...
I understand you're dealing with a stubborn rash that's persisted even after completing your RCHOP chemotherapy and radiation therapy. This is a real concern, and I want to help yo
Non-hodgkins lympoma: Day 7 post-infusion is the WORST. I put it on my calendar. Schedule NOTHING on Day 7....
Thank you for sharing this important insight about your treatment timeline. What you're describing is a very real and documented pattern with Pola-R-CHP chemotherapy polatuzumab ve
Repurposed drug schedule for metastatic breast cancer
I'd be happy to help you understand repurposed drugs medications originally developed for other conditions that are now used in cancer treatment for metastatic breast cancer. Howev
Follicular lymphoma: There are people who have undergone four lines of treatment... because there have been...
I appreciate you sharing this concern about follicular lymphoma and treatment failures. However, I notice your message seems to reference a general question about multiple treatmen
To clarify - Donor CD34+ cells went from 86% to 0%.
Thank you for that critical clarification. This is a notably different finding than I initially interpreted, and it warrants prompt attention from your transplant team. --- What
I had lab work done 5/12/26 including STR for chimerism. Initial result indicated that my CD34+ decreased from 86%...
Thank you for sharing this important lab result. I can help you understand what this finding means in the context of your allogeneic hematopoietic stem cell transplant allo-HSCT fo
What published data support R-CEP in DLBCL? 2. How many patients with DLBCL have they treated with it? 3. Is the...
I appreciate you asking me to be more precise. Let me be direct about what I actually know versus what I don't: 1. Published Data Supporting R-CEP in DLBCL: I cannot identify pro
What side effects should I expect from treatment
Based on your medical profile, you're currently on chemotherapy and targeted therapy erlotinib following radiation for spinal cord compression. Let me break down what to expect fro
What lifestyle changes are recommended for Kidney Cancer patients
I appreciate this clarification. Let me provide you with what's available in current kidney cancer guidelines, along with important context about what the evidence does and doesn't
The patient recently underwent a CT scan prior to her clinic visit. The key findings include: Left Kidney Tumor:...
Thank you for sharing these detailed imaging results and clinical information. I can see this presents a complex picture—significant imaging findings alongside excellent overall he
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare the most relevant questions for your appointment! To give you the best guidance, could you share a bit more context? Tell me about your situation: - W
Rewrite with full clinical detail. Use proper medical terminology. Include dosages, regimen names, biomarker...
1 What is my exact stage and prognosis with small cell lung cancer? Clinical Significance: Accurate staging and prognostic assessment are foundational to treatment planning. Accor
Rewrite in very simple plain language. Short sentences. No medical jargon. Explain every medical term in everyday...
- What is my exact stage and prognosis with small cell lung cancer? Why this matters: Your stage is a number that tells you how far the cancer has spread in your body. Your progno
Which CPL guest in 2025 discussed exercise clinical trials
I appreciate your question, but I need to be transparent with you: I don't have access to a specific database of Cancer Commons Live CPL webinar guests or their 2025 schedule in my
CPL has hosted exercise oncologist and they have presented clinical trials supporting exercise in cancer space
I appreciate you reaching out, but I notice your question got cut off in the message. You mentioned you're looking for information about exercise oncology and clinical trials, whic
What evidence is there for exersice oncology, what clinical trials have been discussed by people in this field
Exercise oncology is a growing field with substantial clinical evidence supporting its benefits for cancer patients. Let me break down what the research shows and highlight key cli
My allo-HSCT (2/27/25) was to treat the tMDS. I recently experienced an M.I., requiring placement of three stents in...
I'm very sorry you experienced a myocardial infarction MI/heart attack. This is serious, and I want to help you understand what may have happened and what questions to ask your car
Are there any known associations between chemotherapy (CHOP), cellular therapies (Auto-HSCT, CAR-T, Allo-HSCT) and...
This is an important question, especially as you're considering treatment options for your MDS. Let me break down what we know about cardiotoxicity heart damage from these therapie
What does a VAF (Variant Allele Frequency) of 0.15% mean
Great question! VAF is an important concept for understanding what your genetic test results mean. Let me break this down: What VAF Measures Variant Allele Frequency tells you w
SORRY FOR ASKING BUT I WANT TO BE SURE. WHAT OFFICIAL MEDICAL GUIDELINES OR STUDIES DID YOU USE TO GENERATE THESE...
You're asking the right question. Here's exactly what I used to answer you about your current situation pT2, Gleason 7, undetectable PSA post-RARP: --- OFFICIAL SOURCES I CITED:
PLEASE FOCUS ONLY ON YOUR REPLIES REGARDING MY EXACT QUESTION. DO NOT INCLUDE INFORMATION ON FUTURE TREATMENTS, ETC....
I appreciate your clear instruction, and I want to be completely honest with you: I notice you haven't actually asked a new question in this message. You've provided: - Context
YOU STOPPED AT: "IMAGING SURVEILLANCE: ├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026) ├─ Chapter 3:...
Let me complete the imaging surveillance section and finish the full source verification. --- SECTION 6 CONTINUED: IMAGING SURVEILLANCE ✅ WHAT I CITED FROM NCCN GUIDELINES ``
YOU STOPPED AT: " PSA NADIR CONCEPT: ├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026) ├─ What it...
Let me complete the source verification for everything else I've discussed with you. --- SECTION 4: RISK STRATIFICATION & PROGNOSIS ✅ WHAT I CITED FROM NCCN GUIDELINES ``` RI
YOU STOPPED AT: "QUESTION #3: What if your PSA rises?...
Let me complete this critical section about biochemical recurrence management. --- QUESTION 3: WHAT IF YOUR PSA RISES? Your Salvage Therapy Options ``` SCENARIO: PSA rises ab
YOU STOPPED AT: "YOUR REVISED MSKCC NOMOGRAM RESULTS With Negative Surgical Margin Status"
Let me complete this calculation and show you how this changes your clinical picture. --- SIDE-BY-SIDE COMPARISON: POSITIVE vs. NEGATIVE MARGIN How Margin Status Changes Your
CAN YOU RUN-IT AGAIN PUTTING NEGATIVE SURGICAL MARGIN (SINCE, IN MY CASE, IT IS NOT SO CLEAL IF IT IS A FOCAL APICAL...
You raise an excellent clinical point. Let me recalculate your nomogram with negative surgical margin status, which is actually a very reasonable interpretation of your pathology r
YOU STIOPPED AT: "WHY THIS ALIGNMENT MAKES SENSE: 1. OBSERVATION IS APPROPRIATE BECAUSE: ├─ Your 72-76%...
Let me finish explaining why observation is appropriate for your situation and what this means for your next steps. --- WHY OBSERVATION IS APPROPRIATE FOR YOUR NOMOGRAM RESULT
Don't see your question?
Ask Navis — our AI — about your specific cancer situation.
Ask Your Own Question